key: cord-0991150-zljddg35
authors: Santos, Gabryella S. P.; Costa, Alinne C.; Picoli, Caroline C.; Rocha, Beatriz G. S.; Sulaiman, Sheu O.; Radicchi, Debora C.; Pinto, Mauro C. X.; Batista, Miguel L.; Amorim, Jaime H.; Azevedo, Vasco A. C.; Resende, Rodrigo R.; Câmara, Niels O. S.; Mintz, Akiva; Birbrair, Alexander
title: Sympathetic nerve-adipocyte interactions in response to acute stress
date: 2021-11-04
journal: J Mol Med (Berl)
DOI: 10.1007/s00109-021-02157-0
sha: 7f1da9e45f9014f5bd03a37c4082de42d7a18cfa
doc_id: 991150
cord_uid: zljddg35

Psychological stress predisposes our body to several disorders. Understanding the cellular and molecular mechanisms involved in the physiological responses to psychological stress is essential for the success of therapeutic applications. New studies show, by using in vivo inducible Cre/loxP-mediated approaches in combination with pharmacological blockage, that sympathetic nerves, activated by psychological stress, induce brown adipocytes to produce IL-6. Strikingly, this cytokine promotes gluconeogenesis in hepatocytes, that results in the decline of tolerance to inflammatory organ damage. The comprehension arising from this research will be crucial for the handling of many inflammatory diseases. Here, we review recent advances in our comprehension of the sympathetic nerve-adipocyte axis in the tissue microenvironment.

Stressful psychological circumstances are frequent in our daily life. The "fight or flight response" is presently welldefined as an evolutionary conserved physiological reaction of the organism to the eminent encounter with a stressor (threat or harmful event) [1] . This process was initially described at the first half of the twentieth century by the American physiologist Walter Bradford Cannon [2] . This phenomenon aims to preserve or restore organism homeostasis in vertebrates [3] . It is characterized by several physiological manifestations, including increase of respiratory and heart rates, rise in temperature, release of stocked energy, elevation in blood supply to skeletal muscles, dilation of eye pupils, among other changes [2, 4] . Nonetheless, although the consequences of this response are usually adaptive [5] , they can also be damaging, affecting organ integrity and being detrimental to health [5, 6] . Hence, a unified in-depth mechanistic comprehension of the "fight or flight response" is crucial for discriminating pathological from physiological outcomes to which it leads, and for improving therapies designed to prevent organ damage resulting from this phenomenon.

The most well-studied effector organ that responds to stress is the adrenal gland, which releases catecholamines and glucocorticoids into the bloodstream [7] . Nonetheless, the fight or flight response also activates the sympathetic nervous system, which has been historically less explored partially due to its diffuse anatomy [8, 9] . Sympathetic nerves innervate most organs and are also involved in various pathophysiological responses to psychological stress [10, 11] . Sympathetic neurotransmitters released by these innervations, such as norepinephrine, ATP, neuropeptide Y, and nitric oxide, may affect the behavior of specific cell types in diverse tissue microenvironments [12, 13] . Albeit sympathetic nerves activated by psychological stress have long been suspected of participating in the origin of many disorders, the cellular and molecular mechanisms involved still remain incompletely understood. Understanding the role of sympathetic nerves and the signaling mechanisms involved during psychological stress may be crucial for the success of clinical applications.

In a recent article in Cell, Qing and colleagues demonstrated elegantly that sympathetic nerves play a central role in the inflammatory organ damage that can be caused by psychological stress [14] . Using state-of-theart technologies, such as sophisticated in vivo inducible genetic methods, including Cre/loxP-mediated systems, in combination with pharmacological approaches, the authors selectively eliminated different components from the tissue microenvironment to dissect the cellular and molecular mechanisms involved in acute stressderived organ damage. The authors found that the level of interleukin-6 (IL-6) induced after psychological stress was higher than of all other cytokines tested. This level was sustained for several hours, and it was independent of circadian oscillations [14] . Interestingly, surgical removal of brown adipose tissue eliminated the increase in IL-6 after psychological stress. Additionally, Qing and colleagues, by using UCP1-Cre/IL-6-floxed mice in which IL-6 is deleted specifically from brown adipocytes, revealed that IL-6 levels after psychological stress decreased significantly in those mice [14] . These data indicated that the major source of IL-6 after psychological stress was brown adipocytes.

Remarkably, the authors discovered that pharmacological sympathetic denervation reduced IL-6 levels induced by psychological stress. Also, specific genetic ablation of β3 adrenergic receptors in brown adipocytes attenuated the levels of stress-induced IL-6, demonstrating that sympathetic nerves control brown adipocytes IL-6 release by β3 adrenergic signaling during acute stress. Moreover, Qing and colleagues showed that sympathetic nerve activation of adipocyte IL-6 secretion leads to hyperglycemia through gluconeogenesis in response to psychological stress [14] . Notably, pharmacologic blockage or genetic deletion of IL-6 receptors in hepatocytes suppressed hepatic gluconeogenesis after psychological stress. Overall, these results indicate that sympathetic nerves induce hyperglycemia in response to acute stress via adipocyte-derived interleukin-6 acting on hepatocytes [14] .

Qing and colleagues demonstrated that lipopolysaccharideinduced inflammation can cause mortality in stressed animals. Strikingly, this mortality was dependent of sympathetic nerves signaling through β3-adrenergic receptors in adipocytes, of IL-6 release by those adipocytes, and of glucose production by hepatocytes in response to . Importantly, the mortality in stressed animals was caused by renal and cardiac damage. Altogether, this study reveals a key role of sympathetic nerves in decreasing tolerance to inflammatory organ damage via adipocyte-derived IL-6 ( Fig. 1) .

This study reveals details of cellular and molecular mechanisms involved in the organism response to acute stress. It also identifies a systemic communication between the peripheral nervous system, brown adipocytes, and hepatocytes. These findings also offer novel therapeutic targets for treatments of disorders characterized by inflammatory organ damage. Here, we discuss the discoveries from this work and evaluate recent advances in our understanding of the influence of sympathetic nerve-adipocyte-hepatocyte axis in the tissue microenvironment.

Qing and colleagues analyzed cell-specific null mutant mice models (Ucp1-CreER/β3-adrenergic receptor-floxed, Ucp1-CreER/IL-6-floxed, and Alb-Cre/IL-6 receptor a-floxed mice), and the principal discoveries from this study are based on the experimental results collected from these mice [14] . A limitation of such approaches is that they rely on the induction of the Cre recombinase [15] [16] [17] . Thus, caveats, that need to be given attention when using these models, include inadequate recombination leading to insufficient gene deletion, off-target Cre expression, and compensatory upregulation of other genes [18, 19] . Therefore, examination of gene expression levels in the targeted cells will clarify the level of achieved gene deletion, and whether there are compensatory changes in the expression of other genes in these specific cells.

Traditionally, it is well established that Ucp1 is expressed by adipocytes [20]. Nevertheless, not all adipocytes have this protein [21] , and Cre-mediated expression based on this gene can be detected in other cells as well, for instance in renal collecting ducts [22] . Additionally, Ucp1 expression was previously detected outside of the adipose tissue as well [23] . Thus, in Ucp1-CreER/β3-adrenergic receptor-floxed and Ucp1-CreER/IL-6-floxed mice, β3-adrenergic receptor and IL-6 may be also eliminated from other cell types outside of the brown adipose tissue. Although these concerns do not change the outcome of this study, it is possible that some of the effects observed in those models are not exclusively due to brown adipocytes.

Brown adipocytes are present in diverse anatomical locations in mice and humans, including dorsal back of the interscapular and subscapular regions, cervical region between scapula and head, supraclavicular region, associated to kidneys, and attached to the thoracic aorta [24-27]. Additionally, they can be found also within the epididymal and inguinal white adipose tissue [28, 29] as beige/brite adipocyte. Qing and colleagues surgically removed intrascapular fat pads, suggesting the importance of brown adipocytes from this site [14] . Nevertheless, in all transgenic models analyzed, genetic deletions of β3-adrenergic receptor and IL-6 were done in brown adipocytes from all locations where they are present. Therefore, it remains to be explored whether the observed phenotype in these transgenic models is due to brown adipocytes from a specific anatomical location, or whether all brown adipocytes contribute to this phenomenon.

Mature adipocytes are the typical residents of the adipose tissue [30-32] and are classified into three distinct types: white, brown, and beige/brite (https:// doi. org/ 10. 1016/j. cmet. 2016. 10. 005). White adipocytes are related to storing triacylglycerides (TGs). The brown adipocytes oxidize lipids to produce heat in part through a UCP1 associated uncoupling of electron transport from ATP production. Beige adipocytes ("brown-like") can also support UCP1independent thermogenesis (https:// doi. org/ 10. 1042/ BCJ20 200298). Beige cells resemble white adipocytes with a shallow basal expression of UCP1, but, like classical brown fat, they respond to cyclic AMP stimulation with high UCP1 Fig. 1 Sympathetic nerve-adipocyte-hepatocyte axis dictates physiologic response to acute psychological stress. Using state-of-the-art technologies, Qing and colleagues demonstrated that, after acute psychological stress, sympathetic nerves induce brown adipocytes to increase circulatory IL-6 levels. IL-6 signals to hepatocytes to increase glucose production via gluconeogenesis leading to hyperglycemia. This results in a decline in the organism tolerance to inflammatory organ damage [14] expression and respiration rates (https:// doi. org/ 10. 1016/j. cell. 2012. 05. 016). Nevertheless, this tissue comprises a variety of other components with important physiological roles, such as pre-adipocytes, mesenchymal stem cells, nerves, macrophages, neutrophils, lymphocytes, fibroblasts, pericytes, endothelial cells, and others [33] [34] [35] [36] . The proportions of the different adipose tissue constituents may vary depending on the pathophysiological condition and the anatomical location [37] . Interestingly, most of these cells produce IL-6 [38]. Qing and colleagues demonstrated that adipocytes are the main source of IL-6 after psychological stress [14] . Future studies will reveal whether other sources of IL-6 also may be activated by sympathetic nerves and play important roles during the "fight or flight response".

Adipocytes have been shown to be heterogeneous, based on molecular markers, embryonic origins, and anatomical locations [39-41]. Qing and colleagues consider brown adipocytes as a homogeneous population in their study [14] . Nonetheless, a recent study revealed the existence of two brown adipocyte subpopulations based on adiponectin expression [42] . This study showed that the two subtypes differ in their functions and metabolic signatures, characterizing them as low and high thermogenic brown adipocytes. Elegantly, by single-brown adipocyte RNA sequencing, it was revealed that there is molecular heterogeneity based on the transcriptomic patterns of the two brown adipocyte subtypes [42] . Curiously, only one of the subpopulations declined in number with aging. Thus, whether only a fraction of brown adipocytes responds, by producing IL-6, to sympathetic nerves in response to acute stress still needs to be elucidated. It would be important to examine whether different brown adipocytes' subsets behave distinctly during sympathetic nerve activation.

Although all rodent brown adipose tissue depots receive sympathetic innervations [43], the tissue microenvironments of these depots differ [44, 45] . For instance, only the pericardial and minor mediastinal brown adipose tissue depots are innervated by parasympathetic nerve fibers [44, 45] . The sympathetic innervations may also vary in their morphologies and functions in different species [46] [47] [48] [49] [50] [51] . Thus, the role of sympathetic neurons in the brown adipose tissue of distinct anatomical locations in particular species should be investigated in future studies.

IL-6 is a prototypical cytokine involved in the enhancement of multiple inflammatory pathways [52] . It can be induced by diverse stimuli, such as invasion of pathogens or other types of inflammation-linked damage [53] . IL-6 has been shown to be involved in both the innate and adaptive immune responses [38, 54] . It also activates the leukocytic chemotaxis towards the injured site [55, 56] . Importantly, decontrolled IL-6 release results in constant inflammation leading to tissue damage [57, 58] . IL-6 signaling involves canonical and non-canonical molecular mechanisms via a membrane bound or a soluble receptor, respectively. In canonical signaling, IL-6 binds to a membrane-anchored IL-6 receptor (IL-6R). This binding promotes an association with gp130, which activates signal transduction [59] . Non-canonical IL-6 signaling is mediated by the binding to a soluble form of IL-6R (sIL-6R) and forming the complex with gp130 [58] . The differences between downstream signaling mechanisms of IL-6 in canonical versus noncanonical pathways depend on the affected cells, leading to the activation of JAK/STAT3 and/or SHP2/Gab/MAPK pathways [59] . Canonical IL-6 signaling is essential in the chemoresistance of ovarian cancer [60] , autoimmune diseases [61] , colitis [62] , and hepatic inflammation [63] , while non-canonical IL-6 signaling influences rheumatoid arthritis, Castleman disease [64] , osteoclastogenesis [65] , and type 2 diabetes [66] . Increased IL-6 levels have been related to a series of stressors such as cold, infection, restraint, fatigue, sleep deprivation, and psychosocial stressors [67] [68] [69] [70] [71] . Thus, IL-6 increase may affect different tissues differently during psychological stress [72] . Future studies should explore whether canonical, non-canonical IL-6 signaling, or both are involved during psychological stress pathogenesis.

IL6 is expressed as distinct isoforms that may be responsible for different functions associated with IL6 signaling. For example, four IL-6 variants were detected in the human lung tissue: native IL-6, IL-6 missing exon 2 (IL-6Δ2), IL-6 missing exon 4 (IL-6Δ4), and IL-6 missing both exons 2 and 4 (IL-6Δ2,4). Nevertheless, proteins were coded exclusively by native IL-6 and IL-6Δ4. The IL-6Δ4 isoform can form a stable complex with IL-6Rα like native IL-6, but not with IL-6Rβ. Thus, IL-6Δ4 might have a regulatory influence on IL-6 signaling [73] . A spliced isoform of IL-6 was also detected in renal cell carcinoma which acts as IL-6 inhibitor [74] . Recently, there were also reported two IL-6 isoforms in turtles subjected to stress homologous to the mammalian IL-6 [67] . The two IL-6 transcripts were named psIL6 and psIL6ns. Future studies should explore whether different IL-6 isoforms act differently in stress-related contexts. Qing and colleagues demonstrate that after acute stress sympathetic nerves induce the increase in the levels of IL-6 which leads to other pathophysiologic effects [14] . It will be interesting to determine whether sympathetic nerves are also responsible for IL-6 increase in other pathological conditions, in which the role of this cytokine is well characterized, such as Alzheimer's disease [75] [76] [77] , Asthma [78, 79] , atherosclerosis [80, 81] , inflammatory bowel disease [82, 83] , nephropathy [84] , liver diseases [85] , and others [38] (Fig. 2) .

Intriguingly, high levels of circulating IL-6 were associated with worse outcomes in COVID-19 patients, bringing attractive possibilities in terms of treatments [86] . An excessive inflammatory reaction is observed in patients infected by the SARS-CoV-2 virus [87] [88] [89] [90] . COVID-19 infection can be characterized as a "cytokine storm" because the infection is followed by an intense inflammatory response with the release of a copious pro-inflammatory cytokines. The cytokine storm can be characterized by destructive systemic inflammation, hyperferritinemia, hemodynamic instability, and multiple organ failure that can lead to death. Multiple pro-inflammatory cytokines, including IFN-γ, TNF-α, IL-1, IL-6, and IL-18, participate in this uncontrolled immune response [87, 91] . IL-6 plays a fundamental role in the harmful systemic hyperactivated immune status, characterized as "cytokine storm". IL-6-induced immune dysregulation is an important feature of SARS-CoV-2 infection, and the increase of this and other cytokines, including TNF-α, is associated with augmented viral load found in the severe form of the disease [91] [92] [93] .

Three drugs that block IL-6 signaling, tocilizumab, sarilumab, and siltuximab, have been proposed to be used against COVID-19 [94, 95] . Yet, the cellular and molecular players involved in COVID-19 pathophysiology still remain poorly understood. It will be interesting to examine whether SARS-Cov-2 virus activates the sympathetic nerves-brown adipocytes axis to produce IL-6. During the pandemic, patients also suffer with social isolation what leads to acute psychological stress, with the possible involvement of sympathetic nerves in the production of IL-6. COVID-19 disease brought fear, lockdown, and precautionary measures that led to psychosocial stress which may result in depression [96] [97] [98] . Acute stress is related to isolated episodic events while chronic stress is associated with an accumulation of several episodic psychological stress events [99] . The prolongation of pandemic restrictions could lead to chronic stress. Although Qing et al. discussed IL-6 regulation of acute stress, IL-6 has been shown to be involved in both acute and chronic stress [71] . High levels of IL-6 are detected in patients with depression [100] . Furthermore, increased IL-6 concentration and systemic inflammation have been reported in psychosocial stress, similar to the observed after COVID-19 infection [100] . In spite of major epidemiological studies, stress . IL-6 plays important roles in the pathogenesis of multiple disorders. Future studies will reveal whether sympathetic nerves are also responsible for IL-6 production in these pathological conditions

has not yet been singled out as an essential risk factor in COVID-19 disease. Nevertheless, reports have shown that psychological stress and depression in COVID-19 patients may worsen disease prognosis [101, 102] . Interestingly, infants and children, which have more abundant brown adipose tissue [103] [104] [105] [106] , are the ones least affected by COVID-19 [107, 108] . This may be due to a variety of reasons, including lower expression of angiotensin-converting enzyme 2 (ACE2) receptors in children [109, 110] , higher COVID-19 comorbidities in adults [111] , increased chronic pro-inflammatory status with age [112] [113] [114] [115] , and others. Thus, it will be important to investigate in depth the mechanisms involved in the production of IL-6 in COVID-19 patients at different ages, exploring the possible cross-talk between sympathetic nerves and brown adipocytes (Fig. 3) .

IL-6 signaling induces distinct acute and chronic pathophysiological effects. Initially, IL-6 is produced in the site of inflammation by the skeletal muscle, adipose tissue, adrenal gland, endothelial cells, and others [71] , leading to the production of C-reactive protein, serum amyloid A, fibrinogen, and other acute-phase proteins [116, 117] . On the other hand, during the chronic response, IL-6 is produced by a variety of leukocytes mediating the switch from innate to adaptive immunity which restores the body homeostasis after inflammation [117, 118] . In obesity, although the main focus of studies has been the targeting of the white adipose tissue, increase in brown adipose tissue has emerged as a promising strategy against this pathology as well [119] . Indeed, ablation of UCP1, the brown-fat-specific uncoupling protein, has been shown sufficient to induce obesity, suggesting that brown adipose tissue may protect against this disease [120] . Nevertheless, an increase in IL-6 has been detected in the circulation and adipose tissue of obese patients [121] [122] [123] , indicating that possibly this increase in IL-6 may be coming from a different source than during acute psychological stress. Interestingly, findings point to different and even sometimes contradictory outcomes when using IL-6 knockout mice. While some showed that these mice develop spontaneous obesity [124] , other studies found different results [125, 126] . Such contradictory findings could be explained only in the frame of a more in-depth investigation on the role of IL-6 coming from different sources (cells/tissues).

In addition to key roles of peripheral innervations within different organs, nerves infiltrate also inside tumors in several tissues, affecting cancer development in different ways [127] [128] [129] [130] [131] [132] [133] [134] . Specifically, sympathetic nerves have been shown necessary for cancer progression [131] . Importantly, clinical studies reveal beneficial effects of treatments that affect the sympathetic nervous system in human cancer patients [135] . Still, the detailed molecular mechanisms by which sympathetic nerves influence cancer progression Fig. 3 Possible role of sympathetic nerves and brown adipocytes in COVID-19 pathogenesis. High levels of circulating IL-6 are associated with worse outcomes in COVID-19 patients. It will be interesting to examine whether SARS-Cov-2 virus activates the sympathetic nerve-brown adipocyte axis to produce IL-6. During the pandemic, patients also suffer with social isolation what leads to acute psychological stress, with the possible involvement of sympathetic nerves in the production of IL-6 remain incompletely understood within the complexity of the tumor microenvironment [133, 136] .

When adipose tissue is invaded by cancer cells, adipocytes act as a supply of lipids for neoplastic cells [137, 138] . Additionally, adipocytes directly interact with malignant cells affecting their behavior, including their proliferation and invasion capacities [139] [140] [141] [142] [143] . Adipocytes may also affect other components within the tumor microenvironment, such as newly formed blood vessels [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] . White and beige adipocytes, within the tumor microenvironment, also produce IL-6, and some of their effects on cancer cells have been attributed to IL-6 signaling [158, 159] . Additionally, brown adipocytes can transform and secrete IL-6 upon other different stimulations [160, 161] . Cancerassociated cachexia is associated with switch from WAT to BAT [162] (https:// doi. org/ 10. 1038/ s41598-018-36626-3). Increased circulating IL-6 levels have been associated with WAT browning, as consequence of the upregulation of the uncoupling protein-1 (UCP1) [162, 163] (https:// doi. org/ 10. 20900/ immun ometa b2020 0032). Experiments blocking IL-6 production by cancer cells show a reduction in browning [162] , which limits cachexia [164] . Additionally, treatment with anti-IL-6 blocks WAT atrophy [162] . The role of the sympathetic nervous system in IL-6 induction of cancerassociated cachexia remains to be explored.

Thus, it will be compelling to examine whether sympathetic nerves also act within tumors via IL-6 derived from intra-tumoral adipocytes (Fig. 4) . New treatments targeting this possible mechanism could potentially be used in the anti-cancer fight, improving patient survival.

Qing and colleagues reveal a novel role of sympathetic nerves increasing circulatory IL-6 via brown adipocytes after psychological stress [14] . Mouse models aim to recreate features of human biology as closely as possible. Nevertheless, to translate animal research into human patients, these discoveries should be in the future validated in human tissues. Although it is known that in humans IL-6 levels increase after stress [14, 165, 166] , the mechanisms involved in this phenomenon remain to be confirmed. It has been implied that β3-adrenergic response in the adipose tissue varies between species [167] . Comparing rodent and human brown adipose tissues, differences have been detected in composition, gene expression profiles, and anatomical location, being more widely dispersed in humans [168, 169] . IL-6 also presents species-specific characteristics, such as binding specificity [170, 171] . Also, the human and rodent IL-6 receptors differ, and tocilizumab does not activate the rodent receptors [172] [173] [174] [175] [176] . It is not yet clear whether these findings could be translated into clinic, thus future studies should examine whether the mechanistic discoveries by Qing et al. (2020) are also valid in humans. Enhancing the accessibility to human biopsies will be essential to achieve this aim. Importantly, although some BAT deposits have been reported [161, [177] [178] [179] [180] , the WAT is the predominant fat type in humans. IL-6 production by WAT has been suggested to participate in the pathophysiology of type 2 diabetes and obesity in humans [66, 181, 182] . Moreover, the white adipose tissue is also innervated by the sympathetic nervous Fig. 4 Potential new mechanism of sympathetic nerve role within the tumor microenvironment. Different nerve fibers, including sympathetic innervations, infiltrate the tumors, and affect their development. The detailed molecular mechanisms by which sympathetic nerves influence cancer progression remain incompletely understood. Future studies should examine whether sympathetic nerves also act within tumors via IL-6 derived from intra-tumoral adipocytes [180, 183, 184] and has been shown to secrete IL-6 [66] . This brings the question of whether the production of IL-6 in humans is activated in the WAT through sympathetic innervations stimulation as well. Thus, albeit IL-6 is secreted in humans from WAT, BAT and beige adipocytes, future work will explore whether and how the sympathetic nervous system is involved in these processes. Interestingly, several ongoing clinical trials are exploring the role of IL-6 biology in multiple human disorders including inflammation, rheumatoid arthritis, COVID-19, pneumonia, cardiovascular diseases, cancer, adipose tissue remodeling, stress, exercise, immune cell regulation, and obesity (Table 1) .

Qing and colleagues provide a new and important insight into the cellular and molecular mechanisms involved in the response to acute psychological stress: Sympathetic nerves induce adipocytes to release IL-6 which activate hepatocytes for gluconeogenesis [14] . This new concept places sympathetic nerves, brown adipocytes, and hepatocytes as central players that might be pharmacologically targeted to alter the physiologic effects of acute psychological stress and improve the organism reactions. Future studies will reveal whether these cross-talks are important also in other physiopathologic conditions. Availability of data and materials Not applicable.

Ethics approval and consent to participate Not applicable. 

The concept of cellular "fight-or-flight" reaction to stress

Fight-or-flight response in the ancient Egyptian novel "Sinuhe

Neural regulation of endocrine and autonomic stress responses

Neuronal control of brown fat activity

Presence and distribution of cholinergic nerves in rat mediastinal brown adipose tissue

Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I Central nervous system Neuroscience

Characterization of the central neural projections to brown, white, and beige adipose tissue

Insights into the neurochemical signature of the innervation of beige fat

CNS origins of the sympathetic nervous system outflow to brown adipose tissue

Sympathetic innervation of the interscapular brown adipose tissue in mouse

Localization of sympathetic postganglionic and parasympathetic preganglionic neurons which innervate different regions of the dog heart

Targeted stellate decentralization: implications for sympathetic control of ventricular electrophysiology

Historical overview of the interleukin-6 family cytokine

Key role of DAMP in inflammation, cancer, and tissue repair

The two-faced cytokine IL-6 in host defense and diseases

Interleukin-6 is a direct mediator of T cell migration

Effects of IL-6 and IL-6 blockade on neutrophil function in vitro and in vivo

IL-6 in inflammation, immunity, and disease

Interleukin-6: biology, signaling and strategies of blockade

Interleukin-6 signaling pathway and its role in kidney disease: an update

IL-6 promotes nuclear translocation of HIF-1alpha to aggravate chemoresistance of ovarian cancer cells

IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation

2021) miR-223 improves intestinal inflammation through inhibiting the IL-6/ STAT3 signaling pathway in dextran sodium sulfate-induced experimental colitis

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti-IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

Combination of IL-6 and sIL-6R differentially regulate varying levels of RANKL-induced osteoclastogenesis through NF-kappaB, ERK and JNK signaling pathways

The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes

A new IL6 isoform in Chinese soft-shelled turtle (Pelodiscus sinesis) discovered: its regulation during cold stress and infection

Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults

The effects of psychological stress on plasma interleukin-6 activity in rats

Beneficial health effects of exercise-the role of IL-6 as a myokine

Role of interleukin-6 in stress, sleep, and fatigue

Interleukin-6 and its receptors: a highly regulated and dynamic system

Identification of a novel IL-6 isoform binding to the endogenous IL-6 receptor

A spliced isoform of interleukin 6 mRNA produced by renal cell carcinoma encodes for an interleukin 6 inhibitor

The role of interleukin-6 signaling in nervous tissue

Sonntag WE (2020) Interleukin 6 reduces allopregnanolone synthesis in the brain and contributes to age-related cognitive decline in mice

IL-6 trans-signaling in the brain influences the metabolic phenotype of the 3xTg-AD mouse model of Alzheimer's disease. Cells 9

Non-redundant functions of IL-6 produced by macrophages and dendritic cells in allergic airway inflammation

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy

Sustained focal vascular inflammation accelerates atherosclerosis in remote arteries. Arterioscler Thromb Vasc Biol ATVBAHA120314387

Variation in interleukin 6 receptor gene associates with risk of Crohn's disease and ulcerative colitis

Interleukin-6 receptor and inflammatory bowel disease: a Mendelian randomization study

Inflammatory targets in diabetic nephropathy

Interleukin-6 gene polymorphisms and susceptibility to liver diseases: a meta-analysis

Baltimore) 98:e18408

SARS-CoV-2 and COVID-19: is interleukin-6 (IL-6)the 'culprit lesion' of ARDS onset? What is there besides tocilizumab? SGP130Fc. Cytokine X 100029

The COVID-19 cytokine storm; what we know so far

Repurposing approved drugs for guiding COVID-19 prophylaxis: a systematic review

COVID-19 pandemic impact on dentists in Latin America's epicenter: Sao-Paulo

Fomites and the environment did not have an important role in COVID-19 transmission in a Brazilian mid-sized city

Cytokine storms in cancer and COVID-19

Translating IL-6 biology into effective treatments

An inflammatory cytokine signature predicts COVID-19 severity and survival

Effective treatment of severe COVID-19 patients with tocilizumab

IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future

Factors associated with psychological distress during the coronavirus disease 2019 (COVID-19) pandemic on the predominantly general population: a systematic review and meta-analysis

Prevalence and predictors of PTSS during COVID-19 outbreak in China hardest-hit areas: gender differences matter

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Chronic and acute stress and the prediction of major depression in women

On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos?

Prevalence and factors associated with psychological burden in COVID-19 patients and their relatives: a prospective observational cohort study

Prevalence and severity of depression, anxiety, stress and perceived stress in hospitalized patients with COVID-19

Pediatric brown adipose tissue: detection, epidemiology, and differences from adults

Relevance of brown adipose tissue in infancy and adolescence

Children's psychological well-being and problem behavior during the COVID-19 pandemic: an online study during the lockdown period in Germany

Parents' stress and children's psychological problems in families facing the COVID-19 outbreak in Italy

How kids' immune systems can evade COVID

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 infections

Nasal gene expression of angiotensin-converting enzyme 2 in children and adults

Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Aging of the innate immune system: an update

The effect of age on thymic function

Inflammaging: a new immune-metabolic viewpoint for age-related diseases

Inflamm-aging. An evolutionary perspective on immunosenescence

Interleukin-6 and the acute phase response

Interleukin-6 and chronic inflammation

Inflammation as a psychophysiological biomarker in chronic psychosocial stress

Mechanisms of impaired brown adipose tissue recruitment in obesity

UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality

Circulating level of interleukin-6 in relation to body mass indices and lipid profile in Egyptian adults with overweight and obesity

Interleukins 6 and 15 levels are higher in subcutaneous adipose tissue, but obesity is associated with their increased content in visceral fat depots

Visceral fat adipokine secretion is associated with systemic inflammation in obese humans

Interleukin-6-deficient mice develop mature-onset obesity

Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice

Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of agerelated obesity

Sensory nerves in the spotlight of the stem cell niche

Nerve growth factor promotes gastric tumorigenesis through aberrant cholinergic signaling

Denervation suppresses gastric tumorigenesis

Adrenergic-neurotrophin feedforward loop promotes pancreatic cancer

Autonomic nerve development contributes to prostate cancer progression

Adrenergic nerves activate an angio-metabolic switch in prostate cancer

Ablation of sensory nerves favours melanoma progression

Chemogenetic modulation of sensory neurons reveals their regulating role on melanoma progression

beta-Blockers and survival among Danish patients with malignant melanoma: a population-based cohort study

C(3)1-TAg in C57BL/6 J background as a model to study mammary tumor development

Obesity and cancer progression: is there a role of fatty acid metabolism?

Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche

Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity

Adipose tissue and adipocytes support tumorigenesis and metastasis

Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion

Interactions between adipocytes and breast cancer cells stimulate cytokine production and drive Src/Sox2/miR-302b-mediated malignant progression

Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration

Obesity and cancer-mechanisms underlying tumour progression and recurrence

Cancer as a matter of fat: the crosstalk between adipose tissue and tumors

Novel peripherally derived neural-like stem cells as therapeutic carriers for treating glioblastomas

Birbrair A, Frenette PS (2016) Niche heterogeneity in the bone marrow

Pericytes in the premetastatic niche

Pericytes cross-talks within the tumor microenvironment

Cross-talk between lung cancer and bones results in neutrophils that promote tumor progression

Endothelial cells as precursors for osteoblasts in the metastatic prostate cancer bone

Promyelocytic leukemia protein in mesenchymal stem cells is essential for leukemia progression

Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome

Glioblastoma-activated pericytes support tumor growth via immunosuppression

Pericyte in oral squamous cell carcinoma: a systematic review

Glioma pericytes promote angiogenesis by producing periostin

Obesity promotes resistance to anti-VEGF therapy in breast cancer by upregulating IL-6 and potentially FGF-2

Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells

beta-Adrenergic stimulation of interleukin-1alpha and interleukin-6 expression in mouse brown adipocytes

Interleukin-6 released from differentiating human beige adipocytes improves browning

A switch from white to brown fat increases energy expenditure in cancer-associated cachexia

Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and browning

Role of interleukin-6 in cachexia: therapeutic implications

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications

Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study

Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men

A classical brown adipose tissue mRNA signature partly overlaps with brite in the supraclavicular region of adult humans

Comparative analysis of microRNA expression in mouse and human brown adipose tissue

Structure-function analysis of interleukin-6 utilizing human/murine chimeric molecules. Involvement of two separate domains in receptor binding

High-and low-affinity receptors for murine interleukin 6. Distinct distribution on B and T cells

Development of an IL-6 inhibitor based on the functional analysis of murine IL-6Ralpha(1)

Characterization of anti-mouse interleukin-6 receptor antibody

Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor

Anti-interleukin 6 receptor antibody treatment in rheumatic disease

Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells

Brown adipose tissue: new challenges for prevention of childhood obesity. a narrative review

The relationship between brown adipose tissue content in supraclavicular fat depots and insulin sensitivity in patients with type 2 diabetes mellitus and prediabetes

Regulators of human white adipose browning: evidence for sympathetic control and sexual dimorphic responses to sprint interval training

Sympathetic nerve innervation is required for beigeing in white fat

Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness

The controversial role of IL-6 in adipose tissue on obesity-induced dysregulation of glucose metabolism

Dual innervation of white adipose tissue: some evidence for parasympathetic nervous system involvement

Neural innervation of white adipose tissue and the control of lipolysis